查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1877426

治療性血液分離術市場：依技術、手術類型、最終用戶、應用、組件、國家及地區分類－全球產業分析、市場規模、市場佔有率及2025-2032年預測

Therapeutic Apheresis Market, By Technology, By Procedure Type, By End User, By Application, By Component, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 386 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年治療性血液分離市場規模為 28.7923 億美元，從 2025 年到 2032 年將以 4.1% 的複合年成長率成長。

治療性血液分離術是一種醫療程序，包括抽取患者血液，對其進行處理以去除特定成分，然後再將其輸回體內。治療性血液分離術市場的主要驅動力是全球自體免疫疾病和神經系統疾病負擔的日益加重，這導致臨床對血漿置換和其他相關程序的需求不斷成長。血液分離術在先進細胞療法（尤其是CAR-T細胞療法和幹細胞療法）的應用日益廣泛，為設備製造商和服務提供者創造了新的收入來源。然而，設備和程序的高昂成本限制了市場成長，阻礙了中低收入國家的普及。目前，市場正快速朝向自動化、人工智慧賦能的血液分離系統轉型，旨在改善患者預後、縮短手術時間並提高安全性。

治療性血液分離市場－市場動態

慢性病盛行率上升預計將推動市場成長。

慢性病盛行率的上升預計將推動血液分離耗材和設備市場的發展。慢性病，也稱為慢性疾病，是指持續時間較長（通常伴隨終生）且通常無法治癒的長期健康狀況。血液分離耗材和設備對於慢性病的治療至關重要，因為它們能夠針對性地去除或採集血液成分，例如用於治療自體免疫疾病、家族性高膽固醇血症、鐮狀細胞貧血症以及幹細胞採集等。例如，美國國家醫學圖書館（一家位於美國的政府醫學圖書館）預測，到2035年，美國50歲及以上成年人中將有近36%的人至少患有一種慢性病，預計到2050年，這一比例將上升至近48%。因此，慢性病盛行率的上升正在推動血液分離耗材和設備市場的發展。

治療性血液分離術市場細分分析：

全球市場按技術、工藝類型、最終用戶、應用、組件和地區進行細分。

此市場細分包含五大類：血漿置換、低密度脂蛋白（LDL）分離、白血球分離、光療和其他。其中，血漿置換在全球血液分離市場中佔有顯著佔有率。其強勁的市場地位得益於自體免疫疾病和神經系統疾病盛行率的上升，而這又受到遺傳易感性和生活方式轉變的驅動。根據國際多發性硬化症聯盟的數據，多發性硬化症患者人數從2020年的280萬增加到2023年的290萬，凸顯了需要治療介入的人不斷擴大。血漿置換透過清除血液中的發炎因子、自體抗體和其他有害物質，在控制此類疾病方面發揮至關重要的作用，從而減輕疾病復發的嚴重程度並縮短復發持續時間。因此，醫療專業人員擴大將此療法作為治療策略的一部分，這也促進了血漿置換市場的持續成長。

從終端使用者角度來看，血庫是治療性血液分離市場中最引人注目且使用率最高的細分市場之一，這得益於其在採集、處理和供應治療及急救所需的血液成分方面發揮的關鍵作用。這些機構常規進行血漿分離術、血小板分離術和白血球分離術等血液分離術，以確保為自體免疫疾病、腫瘤和血液疾病患者提供所需的特殊血液成分。其完善的基礎設施、標準化的操作規程和高捐血量使其能夠滿足對先進血液分離系統和耗材的穩定需求。持續提升捐血者參與度和加強血液採集能力的努力進一步鞏固了此細分市場的重要性。例如，2023年，新加坡榜鵝一號綜合社區中心開設了一家新的血液採集中心，以滿足不斷成長的需求並鼓勵更多人參與捐血，尤其是在年輕人中。這些發展凸顯了建立強大的血液採集網路的重要性日益凸顯，強調了血庫為何仍然是治療性血液分離領域中一個重要且快速發展的組成部分。

治療性血液分離市場—地域性洞察

北美在全球血液分離術市場佔有顯著佔有率。慢性病在北美國家十分普遍，血液系統疾病患者族群龐大。例如，全球癌症觀察站估計，2022年北美將新增約7.17萬例白血病病例。同樣，美國疾病管制與預防中心（CDC）報告稱，2023年鐮狀細胞疾病（SCD）影響約10萬美國人。這凸顯了對最佳治療方案的需求，從而推動了北美血液分離術市場的發展。此外，這些國家的人均消費水準不斷提高，導致醫療支出顯著成長。隨著經濟成長加速，越來越多的人選擇先進的治療方法，進一步促進了市場成長。

美國治療性血液分離市場—國家概況

美國是該地區的主要市場。美國老年人口的成長正在推動市場成長。隨著人口老化，癌症和慢性病病例可能會增加。這一因素將有助於推動區域市場成長。血液相關疾病（如腎臟病、代謝性疾病、癌症和神經系統疾病）負擔日益加重，完善的醫療保健基礎設施以及患者較高的健康意識是推動北美研究市場成長的主要因素。根據白血病和淋巴瘤協會 (LLS) 統計，美國每三分鐘就有一人被診斷出患有血液癌症。 2020 年，美國約有 178,520 人被診斷出罹患白血病、淋巴瘤或骨髓瘤。 2021 年，白血病、淋巴瘤和骨髓瘤占美國 1,898,160 例新確診癌症病例的 9.8%。因此，目標疾病的高發生率推動了市場成長。

治療性血液分離術市場—競爭格局：

治療性血液分離術市場競爭格局較為集中，創新、技術整合和流程效率在差異化競爭中扮演重要角色。該領域的企業主要透過開發先進的血液分離系統來展開競爭，這些系統能夠提高自動化程度、增強安全性並縮短手術時間。耗材、服務合約和培訓計畫是競爭策略的關鍵組成部分，因為醫療機構越來越傾向於選擇能夠提供全面營運支援的供應商。市場參與者也致力於拓展適應症，例如自體免疫疾病、神經系統疾病和細胞療法等應用，以提高臨床相關性和市場接受度。監管部門的批准、循證臨床資料以及與數位監測平台的整合有助於企業確立競爭優勢。

目錄

第1章：治療性血液分離術市場概覽

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
    • 按技術分類的治療性血液分離市場概覽
    • 按手術類型分類的治療性血液分離市場概覽
    • 按最終用戶分類的治療性血液分離市場概覽
    • 按應用領域分類的治療性血液分離市場概覽
    • 治療性血液分離市場按組件分類的概覽
    • 各國治療性血液分離術市場概況
    • 治療性血液分離術市場概覽（按地區分類）
  • 競爭洞察

第3章：治療性血液分離術的關鍵市場趨勢

  • 治療性血液分離術市場促進因素
    • 市場促進因素的影響分析
  • 治療性血液分離術市場限制因素
    • 市場限制因素的影響分析
  • 治療性血液分離術市場機遇
  • 治療性血液分離術市場未來趨勢

第4章：治療性血液分離術產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：治療性血液分離術市場：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：治療性血液分離術市場概況

  • 2024年治療性血液分離市佔率分析
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：治療性血液分離市場－依技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 離心
    • 薄膜過濾

第8章：治療性血液分離術市場－依手術類型分類

  • 概述
    • 依程序類型進行細分佔有率分析
    • 治療性血漿置換（TPE）
    • 細胞耗竭
    • 紅血球置換（RBCX）
    • 其他程式

第9章：治療性血液分離市場－以最終用戶分類

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 專科診所
    • 血庫
    • 門診手術中心

第10章：治療性血液分離市場－依應用領域分類

  • 概述
    • 依程序類型進行細分佔有率分析
    • 神經病學
    • 腫瘤學
    • 鐮形血球貧血症
    • 自體免疫疾病
    • 移植物抗宿主疾病（GVHD）
    • 腎臟病學
    • 家族性高膽固醇血症
    • 實體器官移植

第11章：治療性血液分離市場－按組件分類

  • 概述
    • 按組成部分分類的細分市場佔有率分析
    • 血漿置換
    • 低密度脂蛋白分離術
    • 白血球分離術
    • 光療
    • 其他

第12章：治療性血液分離術市場－依地理分類

  • 介紹
    • 按地域分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美治療性血液分離術鑰匙製造商
    • 北美市場規模及預測（按國家/地區分類）
    • 北美市場規模及預測（依技術分類）
    • 北美市場規模及預測（依手術類型分類）
    • 北美市場規模及預測（依最終用戶分類）
    • 北美市場規模及預測（按應用分類）
    • 北美市場規模及預測（按組件分類）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲治療性血液分離術關鍵設備製造商
    • 歐洲市場規模及預測（按國家/地區分類）
    • 歐洲市場規模及預測（依技術分類）
    • 歐洲市場規模及預測（依手術類型分類）
    • 歐洲市場規模及預測（依最終用戶分類）
    • 歐洲市場規模及預測（按應用領域分類）
    • 歐洲市場規模及預測（按組件分類）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區
    • 概述
    • 亞太地區治療性血液分離術關鍵設備製造商
    • 亞太市場規模及預測（依國家/地區分類）
    • 亞太市場規模及預測（依技術分類）
    • 亞太市場規模及預測（依手術類型分類）
    • 亞太市場規模及預測（依最終用戶分類）
    • 亞太市場規模及預測（按應用分類）
    • 亞太市場規模及預測（依組件分類）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲治療性血液分離術鑰匙製造商
    • 拉丁美洲市場規模及預測（按國家/地區分類）
    • 拉丁美洲市場規模及預測（依技術分類）
    • 拉丁美洲市場規模及預測（依手術類型分類）
    • 拉丁美洲市場規模及預測（按最終用戶分類）
    • 拉丁美洲市場規模及預測（按應用分類）
    • 拉丁美洲規模及預測（按組成部分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲治療性血液分離術關鍵製造商
    • 中東和非洲市場規模及預測（按國家/地區分類）
    • 中東和非洲市場規模及預測（按技術分類）
    • 中東和非洲市場規模及預測（按手術類型分類）
    • 中東和非洲市場規模及預測（按最終用戶分類）
    • 中東和非洲市場規模及預測（按應用分類）
    • 中東和非洲市場規模及預測（按組件分類）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 中東和非洲其他地區

第13章：主要供應商分析－治療性血液分離術產業

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • Baxter Healthcare Corporation
    • Kawasumi Laboratories Inc.
    • Therakos Incorporation
    • Mallinckrodt Plc
    • Asahi Kasei Medical Co.
    • Haemonetics Corporation
    • Miltenyi Biotec
    • Terumo BCT
    • Asahi Kasei Medical
    • B. Braun Melsungen AG
    • Nikkiso Co. Ltd.
    • Cerus Corporation
    • Terumo BCT Inc.
    • Fresenius Kabi USA
    • Medica SpA
    • Others

第14章：360度分析師視角

第15章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5751

The Therapeutic Apheresis Market size was valued at US$ 2,879.23 Million in 2024, expanding at a CAGR of 4.1% from 2025 to 2032.

Therapeutic apheresis is a medical procedure that involves drawing blood from a patient, processing it to remove specific components, and then returning it to the body. The Therapeutic Apheresis market is primarily driven by the growing global burden of autoimmune and neurological disorders, which is increasing clinical demand for plasma exchange and other procedures. The growing use of apheresis in advanced cell therapies, particularly CAR-T and stem-cell treatments, presents a significant opportunity for device manufacturers and service providers to generate new revenue streams. However, market growth is constrained by the high cost of equipment and procedures, preventing widespread adoption in low- and middle-income countries. The market is being shaped by a rapid shift toward automated, AI-enabled apheresis systems designed to improve patient outcomes, reduce procedure time, and increase safety.

Therapeutic Apheresis Market- Market Dynamics

Rise In Chronic Conditions Is Anticipated To Fuel The Market Growth

The rise in chronic conditions is expected to drive the apheresis consumables and equipment market forward. Chronic conditions, also known as chronic diseases, are long-term health conditions that persist for an extended period of time, often for the rest of a person's life, and are typically incurable. Apheresis consumables and equipment are critical for managing chronic diseases because they allow for the targeted removal or collection of blood components in conditions such as autoimmune disorders, familial hypercholesterolemia, sickle cell disease, and stem cell harvest. For instance, the National Library of Medicine, a government medical library based in the United States, predicts that by 2035, nearly 36% of US adults aged 50 and older will have at least one chronic condition, with that figure expected to rise to nearly 48% by 2050. As a result, the rise in chronic conditions is propelling the apheresis consumables and equipment market.

Therapeutic Apheresis Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Technology, Procedure Type, End User, Application, Component, and Region.

The component segmentation, which comprises five major groups, Plasmapheresis, LDL Apheresis, Leukapheresis, Photopheresis, and Others. Among this, plasmapheresis accounted for a significant share of the Global Apheresis Market. Its strong position is supported by the rising prevalence of autoimmune and neurological disorders, driven by genetic predispositions and shifting lifestyle patterns. According to the Multiple Sclerosis International Federation, the number of people living with Multiple Sclerosis increased from 2.8 million in 2020 to 2.9 million in 2023, highlighting the expanding population requiring therapeutic interventions. Plasmapheresis plays a vital role in managing such conditions by removing inflammatory agents, autoantibodies, and other damaging substances from the bloodstream, leading to reduced severity and duration of disease relapses. As a result, healthcare professionals are increasingly recommending this procedure as part of treatment strategies, contributing to the continued growth of the plasmapheresis segment.

Based on End-User segment, Blood banks are one of the most visible and highly utilized segments in the Therapeutic Apheresis Market, owing to their critical role in collecting, processing, and supplying blood components required for therapeutic and emergency medical purposes. These facilities routinely perform apheresis procedures, such as plasmapheresis, plateletpheresis, and leukapheresis, to ensure the availability of specialized blood components for patients suffering from autoimmune, oncological, and hematological diseases. Their established infrastructure, standardized operating protocols, and high donor throughput allow them to meet the steady demand for advanced apheresis systems and consumables. The segment's importance is bolstered by ongoing efforts to increase donor engagement and strengthen blood collection capacity. For instance, in 2023, a new blood collection center was opened at Singapore's One Punggol integrated community hub to meet rising demand and encourage increased donor participation, particularly among young people. Such developments highlight the growing emphasis on establishing strong blood-collection networks, emphasizing why blood banks remain an important and rapidly expanding component of the therapeutic apheresis landscape.

Therapeutic Apheresis Market- Geographical Insights

North America holds a prominent market share in the global apheresis market. Chronic diseases are common in North American countries, and there is a large patient population suffering from hematological diseases. For instance, the Global Cancer Observatory estimates that approximately 71.7 thousand new cases of leukemia will be reported in North America in 2022. Similarly, the Centers for Disease Control and Prevention (CDC) reported in 2023 that sickle cell disease (SCD) affects approximately 100,000 Americans. This necessitates the need for the best therapeutic solutions, which drives the North American Apheresis Market. Furthermore, the per capita consumption in these countries is increasing, resulting in significant growth in health expenditure. Individuals are increasingly opting for advanced therapies as economic growth accelerates, boosting market growth.

United States Therapeutic Apheresis Market- Country Insights

The United States is the region's major market. The increasing geriatric population in the United States is driving market growth. As the population ages, more cancer cases and chronic diseases are likely to emerge. This factor will help to drive regional market growth. The growing burden of blood-related ailments such as kidney disease, metabolic diseases, cancer, and neurological disorders, the presence of established healthcare infrastructure, and high patient awareness levels are the primary factors driving the growth of the studied market in North America. According to the Leukemia & Lymphoma Society (LLS), someone in the United States is diagnosed with blood cancer every three minutes. Approximately 178,520 people in the United States were diagnosed with leukemia, lymphoma, or myeloma in 2020. Leukemia, lymphoma, and myeloma accounted for 9.8% of the 1,898,160 new cancer cases diagnosed in the United States in 2021. As a result, the high incidence of target diseases drives the market's growth.

Therapeutic Apheresis Market- Competitive Landscape:

The therapeutic apheresis market has a moderately consolidated competitive environment, with innovation, technology integration, and procedural efficiency playing important roles in differentiation. Companies in this space compete primarily by developing advanced apheresis systems that provide increased automation, improved safety profiles, and shorter procedure times. Consumables, service contracts, and training programs are critical components of competitive strategy, as healthcare facilities increasingly prefer vendors who provide comprehensive operational support. Market participants are also focusing on expanding indications, such as autoimmune, neurological, and cell-therapy applications, to increase clinical relevance and adoption. Regulatory approvals, evidence-based clinical data, and integration with digital monitoring platforms help to define competitive advantages.

Recent Developments:

In August 2023, TERUMO BCT, INC received FDA approval for a groundbreaking platelet device that converts blood into platelets in a single centrifugation cycle, increasing the speed and reliability of blood component preparation.

In August 2023, Fresenius Kabi AG and Lupagen Inc. have signed a new supply and development agreement. This collaboration focuses on developing technologies to improve the delivery of cell and gene therapies directly to patients in clinical settings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERAPEUTIC APHERESIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Baxter Healthcare Corporation
  • Kawasumi Laboratories Inc.
  • Therakos Incorporation
  • Mallinckrodt Plc
  • Asahi Kasei Medical Co.
  • Haemonetics Corporation
  • Miltenyi Biotec
  • Terumo BCT
  • Asahi Kasei Medical
  • B. Braun Melsungen AG
  • Nikkiso Co. Ltd.
  • Cerus Corporation
  • Terumo BCT Inc.
  • Fresenius Kabi USA
  • Medica S.p.A.
  • Others

GLOBAL THERAPEUTIC APHERESIS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Centrifugation
  • Membrane filtration

GLOBAL THERAPEUTIC APHERESIS MARKET, BY PROCEDURE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Therapeutic plasma exchange (TPE)
  • Cellular depletions
  • Red blood cell exchange (RBCX)
  • Other procedures

GLOBAL THERAPEUTIC APHERESIS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty clinics
  • Blood banks
  • Ambulatory surgical centers

GLOBAL THERAPEUTIC APHERESIS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Neurology
  • Oncology
  • Sickle cell disease
  • Autoimmune disease
  • Graft-versus-host disease (GVHD)
  • Nephrology
  • Familial hypercholesterolemia
  • Transplant of solid organs

GLOBAL THERAPEUTIC APHERESIS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Plasmapheresis
  • LDL Apheresis
  • Leukapheresis
  • Photopheresis
  • Others

GLOBAL THERAPEUTIC APHERESIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Therapeutic Apheresis Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Therapeutic Apheresis Market Snippet by Technology
    • 2.1.2. Therapeutic Apheresis Market Snippet by Procedure Type
    • 2.1.3. Therapeutic Apheresis Market Snippet by End User
    • 2.1.4. Therapeutic Apheresis Market Snippet by Application
    • 2.1.5. Therapeutic Apheresis Market Snippet by Component
    • 2.1.6. Therapeutic Apheresis Market Snippet by Country
    • 2.1.7. Therapeutic Apheresis Market Snippet by Region
  • 2.2. Competitive Insights

3. Therapeutic Apheresis Key Market Trends

  • 3.1. Therapeutic Apheresis Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Therapeutic Apheresis Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Therapeutic Apheresis Market Opportunities
  • 3.4. Therapeutic Apheresis Market Future Trends

4. Therapeutic Apheresis Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Therapeutic Apheresis Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Therapeutic Apheresis Market Landscape

  • 6.1. Therapeutic Apheresis Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Therapeutic Apheresis Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Centrifugation
    • 7.1.3. Membrane filtration

8. Therapeutic Apheresis Market - By Procedure Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Procedure Type, 2024 & 2032 (%)
    • 8.1.2. Therapeutic plasma exchange (TPE)
    • 8.1.3. Cellular depletions
    • 8.1.4. Red blood cell exchange (RBCX)
    • 8.1.5. Other procedures

9. Therapeutic Apheresis Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Specialty clinics
    • 9.1.4. Blood banks
    • 9.1.5. Ambulatory surgical centers

10. Therapeutic Apheresis Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Procedure Type, 2024 & 2032 (%)
    • 10.1.2. Neurology
    • 10.1.3. Oncology
    • 10.1.4. Sickle cell disease
    • 10.1.5. Autoimmune disease
    • 10.1.6. Graft-versus-host disease (GVHD)
    • 10.1.7. Nephrology
    • 10.1.8. Familial hypercholesterolemia
    • 10.1.9. Transplant of solid organs

11. Therapeutic Apheresis Market - By Component

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 11.1.2. Plasmapheresis
    • 11.1.3. LDL Apheresis
    • 11.1.4. Leukapheresis
    • 11.1.5. Photopheresis
    • 11.1.6. Others

12. Therapeutic Apheresis Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Therapeutic Apheresis Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Therapeutic Apheresis Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Therapeutic Apheresis Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Therapeutic Apheresis Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Therapeutic Apheresis Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Therapeutic Apheresis Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Baxter Healthcare Corporation
    • 13.2.2. Kawasumi Laboratories Inc.
    • 13.2.3. Therakos Incorporation
    • 13.2.4. Mallinckrodt Plc
    • 13.2.5. Asahi Kasei Medical Co.
    • 13.2.6. Haemonetics Corporation
    • 13.2.7. Miltenyi Biotec
    • 13.2.8. Terumo BCT
    • 13.2.9. Asahi Kasei Medical
    • 13.2.10. B. Braun Melsungen AG
    • 13.2.11. Nikkiso Co. Ltd.
    • 13.2.12. Cerus Corporation
    • 13.2.13. Terumo BCT Inc.
    • 13.2.14. Fresenius Kabi USA
    • 13.2.15. Medica S.p.A.
    • 13.2.16. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us